Literature DB >> 19756726

Tissue transglutaminase expression in celiac mucosa: an immunohistochemical study.

Julia Gorgun1, Anna Portyanko, Yuri Marakhouski, Eugeni Cherstvoy.   

Abstract

Tissue transglutaminase (tTG) constitutes the main autoantigen in celiac disease (CD). The aim of the study was to clarify weather celiac disease is associated with changes in tTG expression in duodenal mucosa. Tissue transglutaminase was assessed immunohistochemically (clone CUB 7402) in duodenal biopsy specimens from 22 untreated CD patients, ten normal controls (NC) with unremarkable duodenal mucosa, and nine disease nonceliac controls (DC). In 15 CD patients duodenal biopsy specimens were repeatedly assessed after these patients had been prescribed gluten-free diet. Positive pixel count algorithm of ImageScope was used for quantitative evaluation of immunohistochemistry. Tissue transglutaminase expression in superficial epithelium differed significantly between the three groups (p < 0.001). It was increased in DC in relation to NC (p < 0.001) and in CD--in relation to NC (p < 0.001) and DC (p = 0.003). In CD and DC, cryptal epithelium was stained more intensively than in NC (p < 0.001), but there was no difference between CD and DC (p = 0.507). The same pattern was seen in lamina propria. A significant decrease in tTG expression in all the compartments was seen in repeatedly assessed samples. Untreated CD is associated with tTG overexpression, which is reversible. Tissue transglutaminase up-regulation does not seem to be specific for CD and can appear in other pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19756726     DOI: 10.1007/s00428-009-0832-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  31 in total

Review 1.  Transglutaminases in disease.

Authors:  Soo Youl Kim; Thomas M Jeitner; Peter M Steinert
Journal:  Neurochem Int       Date:  2002-01       Impact factor: 3.921

2.  Unexpected role of surface transglutaminase type II in celiac disease.

Authors:  Luigi Maiuri; Carolina Ciacci; Ida Ricciardelli; Loredana Vacca; Valeria Raia; Antonio Rispo; Martin Griffin; Thomas Issekutz; Sonia Quaratino; Marco Londei
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

Review 3.  The role of transglutaminase-2 and its substrates in human diseases.

Authors:  Francesco Facchiano; Antonio Facchiano; Angelo M Facchiano
Journal:  Front Biosci       Date:  2006-05-01

4.  Transglutaminase 2 in the enterocytes is coeliac specific and gluten dependent.

Authors:  F Biagi; J Campanella; U Laforenza; G Gastaldi; S Tritto; M Grazioli; V Villanacci; G R Corazza
Journal:  Dig Liver Dis       Date:  2006-08-17       Impact factor: 4.088

5.  Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease.

Authors:  W Dieterich; B Esslinger; D Trapp; E Hahn; T Huff; W Seilmeier; H Wieser; D Schuppan
Journal:  Gut       Date:  2005-09-27       Impact factor: 23.059

Review 6.  Transglutaminases as targets for pharmacological inhibition.

Authors:  Jolanta M Wodzinska
Journal:  Mini Rev Med Chem       Date:  2005-03       Impact factor: 3.862

7.  Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease.

Authors:  Maria V Barone; Ivana Caputo; Maria T Ribecco; Maria Maglio; Roberto Marzari; Daniele Sblattero; Riccardo Troncone; Salvatore Auricchio; Carla Esposito
Journal:  Gastroenterology       Date:  2007-01-21       Impact factor: 22.682

8.  Human serum transglutaminase and coeliac disease: correlation between serum and mucosal activity in an experimental model of rat small bowel enteropathy.

Authors:  G D'Argenio; I Sorrentini; C Ciacci; S Spagnuolo; R Ventriglia; A de Chiara; G Mazzacca
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

9.  Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia.

Authors:  Jongmin Lee; Yoon-Seong Kim; Dong-Hee Choi; Moon Suk Bang; Tai Ryoon Han; Tong H Joh; Soo-Youl Kim
Journal:  J Biol Chem       Date:  2004-10-07       Impact factor: 5.157

Review 10.  Tissue transglutaminase and the stress response.

Authors:  R Ientile; D Caccamo; M Griffin
Journal:  Amino Acids       Date:  2007-03-28       Impact factor: 3.520

View more
  4 in total

1.  Immunological indicators of coeliac disease activity are not altered by long-term oats challenge.

Authors:  S E J Cooper; N P Kennedy; B M Mohamed; M Abuzakouk; J Dunne; G Byrne; G McDonald; A Davies; C Edwards; J Kelly; C F Feighery
Journal:  Clin Exp Immunol       Date:  2013-03       Impact factor: 4.330

2.  Decreased mucosal expression of intestinal alkaline phosphatase in children with coeliac disease.

Authors:  Kriszta Molnár; Adám Vannay; Erna Sziksz; Nóra Fanni Bánki; Hajnalka Győrffy; András Arató; Antal Dezsőfi; Gabor Veres
Journal:  Virchows Arch       Date:  2012-01-20       Impact factor: 4.064

3.  Younger age at diagnosis predisposes to mucosal recovery in celiac disease on a gluten-free diet: A meta-analysis.

Authors:  Zsolt Szakács; Péter Mátrai; Péter Hegyi; Imre Szabó; Áron Vincze; Márta Balaskó; Bernadett Mosdósi; Patrícia Sarlós; Mária Simon; Katalin Márta; Alexandra Mikó; Dániel Pécsi; Alexandra Demcsák; Judit Bajor
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

4.  Utility of tissue transglutaminase immunohistochemistry in pediatric duodenal biopsies: patterns of expression and role in celiac disease-a clinicopathologic review.

Authors:  Saeeda Almarzooqi; Ronald H Houston; Vinay Prasad
Journal:  Patholog Res Int       Date:  2013-09-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.